CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 167 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00253682
NCT00253682N/ACompleted
CompareCT.gov

Cardiac Status of HAART Exposed Infants of HIV-Infected Mothers (CHAART I)

University of Miami·observational·Posted Nov 15, 2005·Updated Mar 18, 2014

In Brief

An observational study for Cardiovascular Diseases and 4 related conditions. Completed, enrolled 167 participants across 5 sites.

Detailed Summary

This study will determine the impact of highly active antiretroviral therapy (HAART) on the developing cardiovascular system, the evolution of HAART-associated cardiovascular changes over time, and the association between cardiovascular measurements with HAART exposure.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Atherosclerosis, HIV Infections, Cardiomyopathy, Hypertrophic
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), Baylor College of Medicine, University of Illinois at Chicago, Clinical Trials & Surveys Corp (C-TASC), Columbia University, Boston Medical Center

Timeline

N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 15, 2005
Enrollment StartSep 1, 2002
Primary CompletionDec 1, 2006
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 20.6 years ago